Open AccessVaccines against SARS CoV 2 and the vaccination campaign in Italy
Author(s) -
M.C. Ponziani
Publication year - 2021
Publication title -
j. amd
Language(s) - English
Resource type - Journals
ISSN - 2532-4799
DOI - 10.36171/jamd21.24.2.8
Subject(s) - vaccination , pandemic , covid-19 , virology , medicine , viral vector , vaccine efficacy , biology , outbreak , infectious disease (medical specialty) , disease , biochemistry , pathology , gene , recombinant dna
The SARS COV 2 pandemic has created an unprecedented need to manufacture and distribute a safe and effective vaccine to immunize an exceptionally large number of individuals planning diversified vaccination approaches quickly. A few weeks have passed since the sequencing of the viral genome for the design of the first vaccines and a few months for the implementation of the efficacy and safety studies. The article analyzes the types of vaccines available by examining their characteristics, efficacy and safety, also examining some debated issues such as the thrombotic risk of viral vector vaccines. The second part deals with the issue of the vaccination campaign in our country. KEY WORDS vaccination; COVID-19; spike protein; efficacy; safety.